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Zusammenfassung der Habilitationsschrift 
 
Worldwide, cardiovascular diseases (CVD) are the leading cause of death. Several risk factors 
for CVD have been established, among which obesity, diabetes, hypertension, unfavourable lipid 
profile, physical inactivity and smoking are the most common. Most of these risk factors depend on 
diet, either by an excess of caloric intake and subsequent obesity or by a direct impact of nutrients. 
Recently, the role of sugar has received more attention. Its consumption has strongly increased in the 
past decades in the US but also in many European countries, including Switzerland. This increase was 
particularly strong for fructose and was mainly driven by mounting consumption of sugar sweetened 
drinks. Much more than glucose, fructose has an immediate impact on CVD risk factors. The 
consumption of large amounts of fructose can increase serum concentrations of cholesterol, glucose 
and uric acid, and may lead to higher blood pressure. However, the most pronounced change is an 
increase in serum triglycerides which may be accompanied by impaired insulin sensitivity. 
While CVD rates generally go down in the western world, there has recently been a sharp 
increase in developing countries. These regions have skyrocketing population growth and thus deserve 
increasing attention. Representative for the future development of many developing countries is the 
recent history of the Republic of the Seychelles, located in the Indian Ocean. Since the construction of 
the airport in the 1970s, this country has experienced an accelerated epidemiological transition from a 
self-sustaining population living from agriculture and fishing to a service-orientated and consuming 
society. Along with an increasing buying power and the adoption of a western lifestyle, tobacco and 
heavy alcohol use have become more and more popular. Per capita caloric intake has increased 
substantially in the Seychelles and the consumption of sugar sweetened drinks has tripled in the past 
25 years. In Switzerland, there has also been a rise in sugar intake, but the increase was less 
pronounced: per capita consumption increased from 41 to 48 kilo in the past 25 years. In 2001, each 
Swiss inhabitant consumed in average 105 litres of sugar sweetened drinks.  
Surveys are an important tool to monitor diseases and risk factors in a population. Descriptive 
epidemiology can also be used to generate hypothesis about causal relationships which can thereafter 
be tested with clinical trials. Both approaches are necessary in order to detect and explore risk factors 
in a population. Based on these findings, public health measures aimed at reducing population risks 
can be developed and implemented.  
The selected six publications highlight CVD risk factors from an epidemiological and clinical 
perspective. Three papers explore, on a population level, the development and the interaction of CVD 
risk factors and behaviours among each other and with disease parameters. The other three 
publications elucidate the direct impact of risk and protective factors on healthy humans. The first 
epidemiological study shows that the strong and fast increase in obesity prevalence in the Seychelles 
was not only paralleled by a rise of diabetes cases but also of persons with less severe impairments of 
glucose metabolism, such as impaired fasting glucose and impaired glucose tolerance [1]. A large 
4 
 
proportion of diabetes patients were not aware of the disease and about half of all diabetes cases was 
attributable to overweight and obesity. In-depth analysis showed that increasing BMI and deterioration 
of glucose metabolism were gradually associated with increasing insulin resistance. A second study 
revealed that not only diabetes but also less severe impairments of glucose metabolism go along with a 
deterioration of common CVD risk factors including hypertension, dyslipidemia and smoking [2]. 
Intima-media thickness of the carotid and femoral artery can be regarded as CVD outcome since it 
measures irreversible organic vascular changes, described as atherosclerosis. In this publication we 
also found that intima-media thickness gradually increased with increasing impairment of glucose 
metabolism. Interestingly, a part of these associations were still significant after adjustment for 
common CVD risk factors. This suggests that additional factors mediate the effect of glucose 
metabolism impairment on intima-media thickness. The analysis also revealed that adjustment for 
simple measurements (BMI and waist circumference) had similar impact as adjustment for common 
clinical CVD risk factors. This has practical relevance in that these simple measurements are valid 
tools for risk assessment in a population. A novel side-finding of this analysis was that the 
relationships between impaired glucose metabolism and intima-media thickness tended to be larger at 
femoral than carotid levels independently of adjustment. Accordingly, one can speculate whether 
measurement at femoral site could be more useful for risk assessment.  
The two studies show that CVD risk factors can rapidly increase in developing countries and 
may reach or exceeded levels typically found in middle- or high-income countries. This increase is 
mainly driven by fundamental changes in lifestyle. Simple and inexpensive risk monitoring – for 
example the assessment of BMI, family history of CVD and diabetes and capillary glucose level - can 
be as effective as much more extensive examinations. In view of the strong association, early 
prevention of factors leading to obesity is a cornerstone strategy to curb CVD and their risk factors.  
Disadvantageous risk behaviours usually do not occur isolated. They mostly coincide with 
others and build clusters. This is also the case for smoking, cannabis use and heavy alcohol 
consumption. Youth who start with one of these behaviours frequently continue with another. This 
finding of the third epidemiological publication has several public health implications [3]. It is 
important to adopt healthy behaviours early in life since this has the potential to reduce CVD in 
adulthood. Furthermore, clustering of risk factors emphasizes the need to address these behaviours 
within a comprehensive and integrated approach. 
As suggested by the epidemiological studies, sugar sweetened drinks may play an important 
role as CVD risk factor. This was substantiated by the first clinical study that found a strong increase 
in serum triglycerides following high fructose intake during a short period [4]. This increase was 
driven by a boosted hepatic de novo lipogenesis and accompanied by insulin resistance a potential 
precursor of diabetes. As a possible CVD protective factor, fish oil was thought to prevent metabolic 
alterations induced by fructose. This was however only the case for a part of the increase in serum 
triglycerides. Because the high amounts of administrated fructose and the short duration of feeding 
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represented a somewhat unrealistic condition, a second protocol has been developed. Fructose 
administration was prolonged to four weeks but the amount was halved and now corresponded to the 
realistic daily consumption of about 1.5 litres of soda [5]. In view of the strong increase of de novo 
lipogenesis, hepatic fat accumulation could be expected. Therefore, magnetic resonance spectroscopy 
was used in the second study to measure changes in intrahepatic fat. In healthy young men, the lower 
fructose dose led to increased triglyceride and glucose levels but neither to insulin resistance nor to 
intrahepatic fat accumulation. However, alterations in the later two were found in one healthy subject 
who had a first degree relative with type 2 diabetes. This subject had to be excluded from the study but 
constituted a basis for a consecutive study which is not discussed here.  
In the second clinical study, muscle and adipose tissue biopsies were taken from each subject. 
With these samples, changes in expression of 16 genes involved in lipid, sugar and energy metabolism 
were measured. The results were published in a third paper [6]. The expression of a lipogenic enzyme 
was increased. This enzyme favours lipid deposition in muscles and is associated with liver steatosis 
and insulin resistance. In contrast, the expression of an insulin-stimulated receptor was decreased after 
fructose intake, which could be interpreted as first step towards insulin resistance. An activator protein 
that stimulates mitochondrial biogenesis also tended to be less expressed after fructose consumption. 
These findings suggest that an increase in fat deposition in hepatic and muscle cells could indeed be 
expected from fructose consumption. However, the duration of administration was probably too short 
for these young healthy and normal weight males without family history of diabetes.  
 
In conclusion, the fast increase in CVD in many parts of the world is mainly due to modifiable 
risk factors. Particularly for rapidly developing countries, the emerging CVD epidemic is a major 
burden because these countries do not have sufficient resources to effectively monitor, prevent and 
treat CVD. Epidemiological research suggests that the consumption of sugar sweetened drinks could 
be a factor contributing to this increase in CVD. These drinks contain large amounts of fructose, a type 
of sugar whose consumption has over proportionally increased in the past years. Clinical research has 
shown that even amounts typically consumed can lead to metabolic deteriorations which increase 
CVD risk. However, the harmfulness of the effect of fructose strongly depends on the amount 
ingested. Dose dependence applies for most risk factors as well as the fact, that they rarely occur alone 
and that their impact varies significantly between individuals. Fructose is a risk factor that could 
particularly easily be modified because the main source are sugar sweetened drinks. A ban of 
distributors in schools, a stricter regulation of advertisement and a tax on sugar sweetened drinks could 
effectively and inexpensively reduce fructose intake. To assess changes in risk factors in a population, 
few simple measurements are almost as effective as extensive assessments. Inexpensive monitoring 
and prevention of risk factors are of major importance in resource-constrained settings as found in 
developing countries. From a public health perspective both epidemiological and clinical approaches 
are necessary to elucidate the impact of CVD risk factors and the potential for prevention. 
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